Jacobs & Co’s Organon & Co OGN Stock Holding History

Jacobs & Co’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,084	Closed	-$215K	–	128
2021 Q4	$215K	Sell	7,084 -2,444	-26%	-$79.6K	0.02%	118
2021 Q3	$312K	Sell	9,528 -2,132	-18%	-$68.2K	0.04%	102
2021 Q2	$352K	Buy	+11,660	New	+$384K	0.04%	101

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jacobs & Co's OGN Position: Q1 2022 in Review

Jacobs & Co sold out of Organon & Co (OGN) in Q1 2022, closing a stake of 7,084 shares — an estimated $215K sold.

Jacobs & Co first reported a position in OGN in Q2 2021 and held it in 3 quarters. The position peaked at $352K in Q2 2021. 818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

Jacobs & Co reported no remaining Organon & Co position as of Q1 2022 after selling out during the quarter.
Jacobs & Co sold 7,084 Organon & Co shares in Q1 2022, an estimated $215K.
Jacobs & Co first reported a position in Organon & Co in Q2 2021 and held it in 3 quarters.
Jacobs & Co's Organon & Co position peaked at $352K in Q2 2021.
818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Jacobs & Co's 13F filing for Q1 2022, filed 14 Apr 2022.